论文部分内容阅读
FIGO(theInternationalFederationofGynecologyandObstetrics,国际妇产科联盟 )是世界上最著名的妇产科学术团体 ,FIGO所制定各种妇科肿瘤的分期标准已被世界各国妇产科学界广泛采用 ,对统一妇科肿瘤分期、指导临床实践以及肿瘤防治方法的标准化和国际间的交流等方面具有非常重要的促进作用。随着科学的发展和医学的不断进步 ,FI GO妇科肿瘤委员会对这些分期标准进行过多次修改。2 0 0 3年 11月在智利召开的第 17届FIGO世界妇产科会议上 ,妇科肿瘤委员会联合IGCS发表了《妇癌分期和临床实践指南》第 2版。新版本增加了很多新的观点和建议 ,特别是循证医学的证据。尽快采用新的分期标准、采用推荐的成熟的诊疗方案 ,对于规范我国妇科肿瘤的治疗方法、提高诊疗水平 ,并使之尽快与国际先进水平接轨 ,一定会有很大帮助。为了使这些最新成果尽早与广大读者见面 ,本刊邀请中山大学林仲秋教授、浙江大学石一复教授将该书翻译并浓缩为“外阴癌”、“阴道癌”、“宫颈癌”、“子宫体癌”、“卵巢癌”、“输卵管癌”、“妊娠滋养细胞疾病”等 7个专题在本刊分期刊登 ,以飨读者
FIGO (theInternationalFederationofGynecologyandObstetrics, International Union of Obstetrics and Gynecology) is the world’s most famous obstetrics and gynecology academic body, FIGO has developed a variety of gynecologic oncology staging standards have been widely adopted by the world’s gynecological and scientific community, the uniform gynecological tumor staging, guidance Clinical practice and the standardization of cancer prevention and control methods and international exchanges have a very important role in promoting. With the development of science and the continuous improvement of medicine, FI GO Gynecologic Oncology Committee has made many changes to these staging standards. At the 17th FIGO World Conference of Gynecology and Obstetrics, held in Chile in November 2003, the Gynecologic Oncology Board and the IGCS published the second edition of the Guide to Staging of Cancer and Clinical Practice. The new version adds a lot of new ideas and suggestions, especially evidence-based medicine. As soon as possible to adopt a new staging criteria, the use of recommended mature treatment programs, for the regulation of gynecologic oncology treatment methods to improve the diagnosis and treatment level, and make it as soon as possible with the international advanced level, will be of great help. In order to make these latest achievements as soon as possible with the majority of readers, the magazine invited Professor Lin Zhongqiu Sun Yat-sen, Zhejiang University, Professor Shi Yifu translated the book and condensed into “vulvar cancer”, “vaginal cancer”, “cervical cancer”, “ Body cancer ”,“ Ovarian cancer ”,“ Fallopian tube cancer ”,“ Gestational trophoblastic disease ”and other seven topics published in this journal in order to readers